Medical products approved by FDA for Horse Joint Treatment

Polysulfated glycosaminoglycan is a naturally-occurring complex molecule that is the essential building block of the cartilage matrix. Marketed as Adequan® i.m. for horses (Polysulfated glycosaminoglycan ), this product travels into injured joints and stimulates production of new cartilage while relieving the symptoms of non-infectious degenerative joint disease. Adequan® i.m. for equines is the ideal, complete treatment for non-infectious degenerative joint disease. Studies have not been conducted to establish safety in breeding horses. Do not use in horses intended for human consumption.

Non-steroidal anti-inflammatory drugs (NSAIDs) act rapidly and are easily administered for the short term relief of pain and inflammation. Potential side effects are: blood disorders, gastro-intestinal ulcers or renal damage.

Corticosteroids are powerful anti-inflammatory drugs that minimize pain and decrease the inflammation of soft tissue rapidly. They can be valuable when used judiciously. Corticosteroids interrupt not only the inflammatory process, but the repair process as well.

Sodium hyaluronate, often called HA, helps restore the function of the hyaluronic acid within the joint to improve the lubrication, stimulate natural production of HA and generally improve the synovial fluid.

Last update : 05-03-2008 06:44

Average user rating

   (0 vote)

Display 5 of 62 comments